Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Restore EF Observational Study (in High-risk PCI)

NCT04648306 is registered in ClinicalTrials.gov with Abiomed Inc. as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04648306 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Restore EF Observational Study (in High-risk PCI)
Lead sponsor
Abiomed Inc.
Phase
Observational
Overall status
Completed
Start date
September 1, 2019
Completion date
September 30, 2021
Enrollment
406 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

angina, stable, coronary artery disease, nstemi - non-st segment elevation mi, unstable angina